The Health Innovation Network’s National Lipid Optimisation & Familial Hypercholesterolaemia (FH) Programme has delivered huge impact in its goal to reduce the prevalence of cardiovascular disease and its associated health inequalities, according to the programme’s new Impact Report.
The report celebrates the collective achievements of the programme, which has increased the detection of people with FH, improved lipid management outcomes, and driven awareness and action with healthcare professionals and our populations about the importance of cholesterol in cardiovascular risk.
Led by Health Innovation North East and North Cumbria, the programme involved the implementation of NICE endorsed national guidance for lipid management and prevention of cardiovascular disease.
“Health equity is the attainment of the highest level of health for ALL people. Achieving health equity requires valuing everyone equally with focused and ongoing societal efforts to address avoidable inequalities, historical and contemporary injustices, and social determinants of health — and to eliminate disparities in health and health care.” (health.gov) Within the NHS there [...]
Sickle cell disease (SCD) is a serious and lifelong health condition. People with SCD produce unusually shaped red blood cells that can cause problems because they do not live as long as healthy blood cells and can block blood vessels. This can result in suffers experiencing painful episodes, called sickle cell crises, as well as anaemia, [...]
At the Royal Society of Medicine’s Tackling Inequalities conference it was clear from the passion in the room that great progress has been made across the system to better support some of our most under-served communities. To maintain this momentum, we must not just embed tackling health and healthcare inequalities in all that we do, [...]
